sodium chlorid 0,9% — Competitive Intelligence Brief

sodium chlorid 0,9% (sodium chlorid 0,9%) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement / Crystalloid fluid. Area: General supportive care / Fluid and electrolyte management.

marketed Electrolyte replacement / Crystalloid fluid General supportive care / Fluid and electrolyte management Small molecule

Target snapshot

sodium chlorid 0,9% (sodium chlorid 0,9%) — Helsinki University Central Hospital. Sodium chloride 0.9% is an isotonic saline solution that restores and maintains fluid and electrolyte balance in the body.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
sodium chlorid 0,9% TARGET	sodium chlorid 0,9%	Helsinki University Central Hospital	marketed	Electrolyte replacement / Crystalloid fluid
Sterile Sodium Chloride	Sterile Sodium Chloride	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	marketed	Electrolyte replacement / Crystalloid fluid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement / Crystalloid fluid class)

1. Helsinki University Central Hospital · 1 drug in this class
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 drug in this class